Improving the predictive ability of the pediatric end-stage liver disease score for young children awaiting liver transplant
- PMID: 32306489
- DOI: 10.1111/ajt.15925
Improving the predictive ability of the pediatric end-stage liver disease score for young children awaiting liver transplant
Abstract
The current pediatric end-stage liver disease (PELD) score underestimates pediatric waitlist mortality. Children frequently require PELD exception points to achieve appropriate priority ranking. We developed a new PELD score using serum sodium, creatinine, and updated original PELD components to more accurately rank children and equalize children's mortality risk with the age-standardized mortality rate of adults. We included children aged younger than 12 years with chronic liver disease, listed for deceased donor livers January 1, 2005-December 31, 2017. Pediatric candidates (n = 5111) were followed from listing to the earliest of waitlist mortality (death or removal from the list due to being too sick to undergo transplant, n = 339) or 180 days. We incorporated linear splines for the current components of PELD and added sodium and creatinine to the equation. The updated PELD-Na-Cr had a cross-validated AUC ROC of 0.854, vs 0.799 for the original PELD. PELD-Na-Cr required 9.44 additional points to equalize children's mortality risk with the age-standardized mortality rate of adults. PELD-Na-Cr better ordered the sickest children and should better prioritize children relative to adults. As a result, PELD-Na-Cr could increase pediatric transplant rates and reduce pediatric liver transplant waitlist mortality.
© 2020 Published 2020. This article is a U.S. Government work and is in the public domain in the USA.
Comment in
-
Competing risks and the risks of children and adults competing for livers.Am J Transplant. 2021 Jan;21(1):13-14. doi: 10.1111/ajt.16158. Epub 2020 Jul 25. Am J Transplant. 2021. PMID: 32564513 Free PMC article. No abstract available.
References
REFERENCES
-
- Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464-470.
-
- Elwir S, Lake J. Current status of liver allocation in the United States. Gastroenterol Hepatol (NY). 2016;12(3):166-170.
-
- McDiarmid SV, Anand R, Lindblad AS. Principal Investigators and Institutions of the Studies of Pediatric Liver Transplantation (SPLIT) Research Group. Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation. Transplantation. 2002;74(2):173-181.
-
- Mazariegos G, Anand R, Mcdiarmid S, et al. Validation of PELD severity score in a pediatric transplant candidate database. Am J Transplant. 2002;2(S3):249-276 [abstract 451].
-
- Chang C-C, Bryce CL, Shneider BL, et al. Accuracy of the pediatric end-stage liver disease score in estimating pretransplant mortality among pediatric liver transplant candidates. JAMA Pediatr. 2018;172(11):1070-1077.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials